Use of Medications to Reduce Cardiovascular Risk Among Individuals With Psychotic Disorders and Type 2 Diabetes

Schizophrenia Research - Netherlands
doi 10.1016/j.schres.2008.02.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Beliefs About Antipsychotic Versus Hypoglycemic Medications Among Individuals With Serious Mental Illness and Type 2 Diabetes

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2012English

The Incremental Burden of Obesity and Sleep Disorders Among Individuals With Type 2 Diabetes Mellitus

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Is Statin Use Safe in Individuals With Psychotic Disorders?

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2008English

Risk of Cardiovascular Event and Mortality in Relation to Refill and Guideline Adherence to Lipid-Lowering Medications Among Patients With Type 2 Diabetes Mellitus in Sweden

BMJ Open Diabetes Research and Care
EndocrinologyMetabolismDiabetes
2019English

Increased Serum Calcium Levels and Risk of Type 2 Diabetes in Individuals at High Cardiovascular Risk

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2014English

Type 2 Diabetes and Cardiovascular Risk Factors

Current Medical Research and Opinion
Medicine
2011English

Cardiovascular Risk in Patients With Type 2 Diabetes

CMAJ
Medicine
2005English

Antihypertensive Medications and the Risk of Incident Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2006English

Acanthosis Nigricans: Relation to Risk of Type 2 Diabetes and Cardiovascular Diseases Among Jamaican Adolescents

Integrative Food, Nutrition and Metabolism
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy